Home/Filings/4/0001140361-10-021251
4//SEC Filing

Goldstein David S. 4

Accession 0001140361-10-021251

CIK 0001375247other

Filed

May 13, 8:00 PM ET

Accepted

May 14, 1:10 PM ET

Size

21.3 KB

Accession

0001140361-10-021251

Insider Transaction Report

Form 4
Period: 2010-05-12
Goldstein David S.
Executive Vice President
Transactions
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2010-05-1241,667208,751 total
    Exercise: $8.40Exp: 2015-03-01Common Stock (41,667 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2010-05-12150208,601 total
    Exercise: $10.80Exp: 2015-10-31Common Stock (150 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2010-05-138,184200,417 total
    Exercise: $10.80Exp: 2015-10-31Common Stock (8,184 underlying)
  • Exercise/Conversion

    Common Stock

    2010-05-12$8.40/sh+41,667$350,00364,167 total
  • Exercise/Conversion

    Common Stock

    2010-05-12$10.80/sh+150$1,62064,317 total
  • Sale

    Common Stock

    2010-05-12$13.63/sh41,817$569,92822,500 total
  • Exercise/Conversion

    Common Stock

    2010-05-13$10.80/sh+8,184$88,38730,684 total
  • Exercise/Conversion

    Common Stock

    2010-05-13$10.00/sh+417$4,17031,101 total
  • Sale

    Common Stock

    2010-05-13$13.55/sh8,601$116,57022,500 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2010-05-13417200,000 total
    Exercise: $10.00Exp: 2011-03-31Common Stock (417 underlying)
Footnotes (3)
  • [F1]Such transaction was executed in multiple trades at prices ranging from $13.42 to $13.91. The price reported reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the trades were effected.
  • [F2]Such transaction was executed in multiple trades at prices ranging from $13.50 to $13.64. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the trades were effected.
  • [F3]Fully vested and immediately exercisable.

Documents

1 file

Issuer

Obagi Medical Products, Inc.

CIK 0001375247

Entity typeother

Related Parties

1
  • filerCIK 0001382901

Filing Metadata

Form type
4
Filed
May 13, 8:00 PM ET
Accepted
May 14, 1:10 PM ET
Size
21.3 KB